• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Forbes' 10th Annual Healthcare Summit Will Convene Leaders To Discuss Breakthrough Solutions for the Next Decade

    11/4/21 11:00:00 AM ET
    $OPA
    Newspapers/Magazines
    Consumer Discretionary
    Get the next $OPA alert in real time by email

    With a focus on "Breakthrough Solutions for the Next Decade," the 10th Annual Forbes Healthcare Summit taking place virtually on Thursday, December 2, will convene influential leaders from traditional healthcare companies, as well as the minds behind the innovations that are improving medical care treatment and delivery from outside the industry.

    • Forbes Healthcare Summit's Top 10 Leaders of the Decade - at this year's 10th anniversary Summit, Forbes is proud to recognize 10 leaders who have greatly influenced progress in healthcare, medicine and science. Through their inspirational stories they will share what they are most excited about in healthcare for the decade ahead that will change the sector for the better.
    • Power Pairings: A signature feature of this year's Summit highlights the partnerships driving more sustainable healthcare delivery to produce a healthier world for all. Our power pairings include forward-looking alliances: Anthem & IBM; Northwell Health & TIAA; Uber & Centene Corporation; CRISPR Therapeutics & Vertex; Humana & Papa and more.
    • Summit Solutions: Once a year for the past decade, Forbes has given voice to innovators' ideas. With a primary focus on putting the patient at the center of care, sector leaders will discuss topics such as: how to reduce barriers to healthcare by addressing social determinants; new funding approaches for startups and innovative healthcare payment models; building the next generation of biopharma; transforming care through AI; entrepreneurial solutions for loneliness and building resiliency; and brain health including how to eradicate any stigma around mental health challenges.

    This year's agenda provides a roadmap across four areas and aims to set out a vision for 2030. The four areas include:

    • Value Creation & Next Generation Healthcare Models
    • Increasing Access, Affordability and Improving Outcomes
    • Whole Person Care: Healing the Brain and Body
    • Investing in Technology, Talent, Innovation & Breakthrough Medicine

    "The last 10 years have seen unprecedented advances in the healthcare and medical industry," said Steve Forbes, Chairman & Editor-in-Chief, Forbes. "As we emerge from the COVID-19 pandemic and look ahead to the decade to come, advancing health security, equity and care through innovative thinking, collaboration and investment has never been more important."

    Forbes has convened a world-class roster of speakers, including:

    • Mohamed Abou Shousha, M.D., Ph.D., Founder & Chief Executive Officer, Heru
    • Jean Accius, Ph.D., Senior Vice President, Global Thought Leadership, AARP
    • Eren Bali, Chief Executive Officer & Cofounder, Carbon Health (Forbes 30 Under 30 Alum)
    • Megan Blewett, Ph.D., Cofounder, Stealth Newco (Forbes 30 Under 30 Alum)
    • Gail K. Boudreaux, President & Chief Executive Officer, Anthem
    • Rosalind (Roz) Brewer, Chief Executive Officer, Walgreens Boots Alliance
    • Jim Breyer, Founder & Chief Executive Officer, Breyer Capital
    • Chiquita Brooks-LaSure, Administrator, Centers for Medicare & Medicaid Services (CMS)
    • Bruce D. Broussard, President & Chief Executive Officer, Humana
    • Lloyd H. Dean, Chief Executive Officer, CommonSpirit Health
    • Michael J. Dowling, President & Chief Executive Officer, Northwell Health (Honoree: Top 10 Leaders of the Decade)
    • Thasunda Brown Duckett, President & Chief Executive Officer, TIAA
    • Paul Farmer, M.D., Ph.D., Kolokotrones University Professor, Harvard Medical School; Cofounder, Partners In Health (Honoree: Top 10 Leaders of the Decade)
    • Judith R. Faulkner, Chief Executive Officer & Founder, Epic (Honoree: Top 10 Leaders of the Decade)
    • Mike Federle, Chief Executive Officer, Forbes
    • Fei-Fei Li, Ph.D., Sequoia Professor, Computer Science, Stanford University; Co-Director, Stanford Institute for Human-Centered AI (HAI)
    • Moira Forbes, Executive Vice President, Forbes; President & Publisher, ForbesWomen
    • Steve Forbes, Chairman & Editor-in-Chief, Forbes
    • Kenneth C. Frazier, Executive Chairman of the Board, Merck & Co., Inc. (Honoree: Top 10 Leaders of the Decade)
    • Nicole Gaudelli, Ph.D., Inventor, Beam Therapeutics
    • Katherine High, M.D., President, Therapeutics, AskBio
    • Deeptee Jain, M.D., Assistant Professor of Orthopaedic and Neurologic Surgery, Washington University
    • Bruce Japsen, Senior Healthcare Contributor, Forbes
    • Katie Jennings, Staff Writer, Health, Forbes
    • Reshma Kewalramani, M.D., President & Chief Executive Officer, Vertex
    • Dara Khosrowshahi, Chief Executive Officer, Uber
    • Stephen K. Klasko, M.D., M.B.A., President, Thomas Jefferson University and Chief Executive Officer, Jefferson Health
    • Alexander R. Knapp, Senior Editor, Science & Healthcare, Forbes
    • April Koh, Cofounder & Chief Executive Officer, Spring Health (Forbes 30 Under 30 Alum)
    • Arvind Krishna, Chairman & Chief Executive Officer, IBM
    • Samarth Kulkarni, Ph.D., Chief Executive Officer, CRISPR Therapeutics
    • Karen S. Lynch, President & Chief Executive Officer, CVS Health
    • Michelle McMurry-Heath, M.D., Ph.D., President & Chief Executive Officer, Biotechnology Innovation Organization (BIO)
    • Valerie Montgomery Rice, M.D., President & Chief Executive Officer, Morehouse School of Medicine
    • Satya Nadella, Chairman & Chief Executive Officer, Microsoft
    • Michael Neidorff, Chairman, President and Chief Executive Officer, Centene Corporation
    • Robert Nelsen, Cofounder and Managing Director, ARCH Venture Partners (Honoree: Top 10 Leaders of the Decade)
    • Mehmet C. Oz, M.D., Cofounder, Sharecare Inc. and Host, "The Dr. Oz Show"
    • Andrew Parker, Founder & Chief Executive Officer, Papa
    • Stefano Pessina, Executive Chairman, Walgreens Boots Alliance (Honoree: Top 10 Leaders of the Decade)
    • Fay Rotenberg, President & Chief Executive Officer, Firefly Health
    • Martine Rothblatt, Ph.D., Founder, Chairperson & Chief Executive Officer, United Therapeutics Corporation (Honoree: Top 10 Leaders of the Decade)
    • Avik Roy, Policy Editor, Forbes; President, Foundation for Research on Equal Opportunity
    • Reshma Shetty, Ph.D., Cofounder, Ginkgo Bioworks
    • Francis Suarez, Mayor, City of Miami
    • Hemant Taneja, Managing Partner, General Catalyst
    • Glen Tullman, Chairman & Chief Executive Officer, Transcarent (Honoree: Top 10 Leaders of the Decade)
    • Alexander R. Vaccaro, M.D, Ph.D., M.B.A., Head Spine Consultant, Philadelphia Eagles and President, Rothman Orthopaedic Institute
    • Sir Andrew Witty, Chief Executive Officer, UnitedHealth Group

    Presenting sponsors for the 2021 Healthcare Summit are AARP and Northwell Health.

    For more information about the 2021 Forbes Healthcare Summit and the speaker lineup, visit: 2021 Forbes Healthcare Summit: Breakthrough Solutions for the Next Decade

    To join the conversation online, follow #ForbesHealth

    About Forbes

    Forbes champions success by celebrating those who have made it, and those who aspire to make it. Forbes convenes and curates the most influential leaders and entrepreneurs who are driving change, transforming business and making a significant impact on the world. The Forbes brand today reaches more than 150 million people worldwide through its trusted journalism, signature LIVE and Forbes Virtual events, custom marketing programs and 44 licensed local editions in 77 countries. Forbes Media's brand extensions include real estate, education and financial services license agreements. Forbes recently announced plans to go public through a business combination with Magnum Opus (NYSE:OPA), a special purpose acquisition company (SPAC), which is expected to close in Q4 of this year or Q1 of next year.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20211104005922/en/

    Get the next $OPA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OPA

    DatePrice TargetRatingAnalyst
    3/2/2022$15.00Buy
    The Benchmark Company
    3/2/2022$15.00Buy
    Benchmark
    10/21/2021$10.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $OPA
    SEC Filings

    View All

    SEC Form 25-NSE filed by Magnum Opus Acquisition Limited

    25-NSE - Magnum Opus Acquisition Ltd (0001843121) (Subject)

    2/8/24 8:48:43 AM ET
    $OPA
    Newspapers/Magazines
    Consumer Discretionary

    Magnum Opus Acquisition Limited filed SEC Form 8-K: Other Events

    8-K - Magnum Opus Acquisition Ltd (0001843121) (Filer)

    1/22/24 4:05:27 PM ET
    $OPA
    Newspapers/Magazines
    Consumer Discretionary

    SEC Form NT 10-Q filed by Magnum Opus Acquisition Limited

    NT 10-Q - Magnum Opus Acquisition Ltd (0001843121) (Filer)

    11/14/23 6:13:55 AM ET
    $OPA
    Newspapers/Magazines
    Consumer Discretionary

    $OPA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    The Benchmark Company initiated coverage on Magnum Opus Acquisition with a new price target

    The Benchmark Company initiated coverage of Magnum Opus Acquisition with a rating of Buy and set a new price target of $15.00

    3/2/22 7:38:15 AM ET
    $OPA
    Newspapers/Magazines
    Consumer Discretionary

    Benchmark initiated coverage on Magnum Opus Acquisition with a new price target

    Benchmark initiated coverage of Magnum Opus Acquisition with a rating of Buy and set a new price target of $15.00

    3/2/22 5:00:53 AM ET
    $OPA
    Newspapers/Magazines
    Consumer Discretionary

    Cantor Fitzgerald initiated coverage on Magnum Opus Acquisition with a new price target

    Cantor Fitzgerald initiated coverage of Magnum Opus Acquisition with a rating of Overweight and set a new price target of $10.00

    10/21/21 7:28:05 AM ET
    $OPA
    Newspapers/Magazines
    Consumer Discretionary

    $OPA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Magnum Opus Sponsors Llc

    3 - Magnum Opus Acquisition Ltd (0001843121) (Issuer)

    11/18/22 6:02:01 AM ET
    $OPA
    Newspapers/Magazines
    Consumer Discretionary

    $OPA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Magnum Opus Receives New York Stock Exchange Notice Regarding Late Form 10-Q Filing

    HONG KONG, Aug. 25, 2023 /PRNewswire/ -- Magnum Opus Acquisition Limited (NYSE:OPA) ("Magnum Opus" or the "Company") announces that on August 22, 2023, as a result of the Company's failure to timely file with the Securities and Exchange Commission ("SEC") its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the "June 2023 Form 10-Q"), it received a notice from the New York Stock Exchange (the "NYSE") stating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual (the "NYSE Rules"). Under the NYSE Rules, the Company has six months from the due date of the June 2023 Form 10-Q, or until February 21, 2024 (the "Deadline"), to file the June

    8/25/23 6:50:00 AM ET
    $OPA
    Newspapers/Magazines
    Consumer Discretionary

    Asia Innovations Group, a Leading Mobile Social Platform in Emerging Markets, to Become a Publicly Listed Company Through Merger with Magnum Opus Acquisition Limited (NYSE: OPA)

    Largest Consumer Internet SPAC Merger announced YTD in 2022 SINGAPORE and NEW YORK, Sept. 30, 2022 /PRNewswire/ -- Asia Innovations Group Limited ("ASIG" or the "Company") today announced that it has entered into a definitive merger agreement (the "Merger Agreement") with Magnum Opus Acquisition Limited (NYSE:OPA) ("OPA"), a special purpose acquisition company. The proposed business combination transaction (the "Business Combination") provides for an equity valuation of $2.5 billion for the combined company. The proposed transaction represents the largest consumer Internet SPAC merger announced year to date in 2022.  Transaction Highlights ASIG operates an integrated platform of products de

    9/30/22 5:08:00 AM ET
    $OPA
    Newspapers/Magazines
    Consumer Discretionary

    Magnum Opus Receives New York Stock Exchange Notice Regarding Late Form 10-Q Filing

    HONG KONG, Aug. 30, 2022 /PRNewswire/ -- Magnum Opus Acquisition Limited (NYSE:OPA) ("Magnum Opus" or the "Company") announces that on August 23, 2022, as a result of the Company's inability to timely file with the Securities and Exchange Commission ("SEC") its Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 (the "Form 10-Q"), it received a notice from the New York Stock Exchange (the "NYSE") stating that the Company is not in compliance with the NYSE American's continued listing requirements under the timely filing criteria established in the NYSE American Company Guide. Under the Section 1007 of the NYSE American Company Guide, the Company could be granted up to 12 months

    8/30/22 7:00:00 AM ET
    $OPA
    Newspapers/Magazines
    Consumer Discretionary

    $OPA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Magnum Opus Acquisition Limited

    SC 13G - Magnum Opus Acquisition Ltd (0001843121) (Subject)

    2/14/24 5:13:04 PM ET
    $OPA
    Newspapers/Magazines
    Consumer Discretionary

    SEC Form SC 13G filed by Magnum Opus Acquisition Limited

    SC 13G - Magnum Opus Acquisition Ltd (0001843121) (Subject)

    2/14/24 1:06:28 PM ET
    $OPA
    Newspapers/Magazines
    Consumer Discretionary

    SEC Form SC 13G filed by Magnum Opus Acquisition Limited

    SC 13G - Magnum Opus Acquisition Ltd (0001843121) (Subject)

    2/14/24 9:38:26 AM ET
    $OPA
    Newspapers/Magazines
    Consumer Discretionary